Advancing ophthalmic drug discovery
Advancing ophthalmic drug discovery
Experimentica Ltd. is a contract research organization (ophthalmic CRO) dedicated to developing and offering novel preclinical ocular models and services to clients in the pharmaceutical, biotech and academic sectors.
We offer the preclinical development pipeline with an industry leading portfolio of in vitro, ex vivo and in vivo models. Choose one of the categories below to learn more:
TESTIMONIALS
-
Thank you for all of your excellent work. I’ve done about 6 or 7 studies with various CRO's over the past year. The breadth of your technical capabilities, scientific expertise, communication, speed, and quality of the report and output far exceeds anything I have received in other collaborations.
Switzerland-based biotech company
-
After discussing dry eye models with several organizations, the expertise at Experimentica stood out head and shoulders above the rest. The care and detail of your model, your insight into the disease and ability to understand our particular mechanism and needs was excellent.
US-based biotech company
-
I wanted to personally thank you for all your help and support over the last two years. We certainly did some great work together, and I look forward to working with you on future projects.
US-based biotech company
-
Experimentica’s team was instrumental in the training of our clinician-scientists by offering internship opportunities and research support. We are impressed by the quality of your work and the in-depth scientific knowledge of your entire team. I look forward to continuing this successful collaboration.
Professor and Chair of Ophthalmology, Academic Medical Center, European Union
LATEST NEWS
A summary of 2018 and a preview of 2019
An overview of main activities and advancements at Experimentica Ltd. in 2018 ... Read More
New Board of Directors announced
Experimentica Ltd., a global contract research organization that specializes in preclinical models for ophthalmic diseases, is pleased to announce its ... Read More
New insights to the supporting mechanism of fluid management in the neural retina
Angiopoietin-4 was identified as the first growth factor having a venous-specific function in the mouse retina, according to a publication ... Read More
Subscribe to Our Newsletter!
We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkNoPrivacy policy